CLINICAL_TRIALS
trial_result
· 2021-07-07
Clinical Trial Update: Empiric Therapy of Patients With Persistent Fever and Agranulocytosis Using Caspofungin [Phase 2]
Summary
Phase 2 trial update evaluating caspofungin for empiric therapy in patients with persistent fever and agranulocytosis.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Cttq | Conditions: Fungal Infection | Phase 2 | Status: COMPLETED